We are pleased to share with you the news that Gyros Protein Technologies Holding AB (“Gyros”) has been acquired by Mesa Laboratories, Inc. (NASDAQ: MLAB) and will become the foundation of a new division within Mesa Laboratories, called Biopharmaceutical Development. We will continue to lead the business and the current Gyros Protein Technologies organization, with both the immunoassays and peptide synthesis business units remaining intact to continue to meet your needs.
Combining Gyros Protein Technologies’ capabilities in high throughput nanoliter scale immunoassays and automated peptide synthesis for biotherapeutics development and manufacturing with Mesa’s customer-centric operating culture will enable us to accelerate our new product development and further enhance our customer support capabilities for research, clinical development and process applications.
What does this mean for you today?
Providing exceptional customer service and support remains a key focus for Gyros Protein Technologies, and our team will maintain a ‘business as usual’ policy as we go through the process of integration. Customers should continue to work with Gyros Protein Technologies teams as they have done to date, for sales, service, product information and ordering.
What does this mean for you in the future?
Gyros Protein Technologies’ leadership team and employees have many years of experience within Gyros Protein Technologies and within the life sciences industry. Mesa Labs is committed to developing the company further in the field of biologics-based technologies. Combining this strength with the resources and capabilities of Mesa Labs will enable faster development of innovative platforms (hardware and software), reagents and consumables to meet the evolving needs of research and regulatory requirements.
We hope you will be as excited about this move as we are. In the meantime, if you have any questions or concerns you would like to discuss, please don’t hesitate to contact me or any member of the Gyros Protein Technologies team. A link to the press release on our website is provided below.
VP and GM Gyros Protein Technologies
30 Technology Drive, Suite 1F
Warren, NJ 07059 USA